U.S. Renal Care expands access to medium cut‑off dialyzers, aiming to improve hemodialysis outcomes for ESRD patients
Executive summary: U.S. Renal Care announced on July 30, 2026 that it is increasing the availability of medium cut‑off dialyzers to support expanded hemodialysis treatments for patients with end‑stage kidney disease. Medium cut‑off dialyzers can remove larger middle‑molecules, potentially reducing inflammation and improving quality of life, which may affect clinical practice and reimbursement in the dialysis market.
Who is involved: U.S. Renal Care (USRC), dialysis clinics within its network, patients receiving hemodialysis, and regulators such as the FDA and CMS.
Likely next: USRC plans to deploy the dialyzers in 150 of its clinics by Q1 2027, while the FDA is expected to complete its 510(k) review by October 2026 and CMS may introduce a new reimbursement code effective January 2027.
U.S. Renal Care announced on July 30, 2026 that it is increasing the availability of medium cut‑off dialyzers to support expanded hemodialysis treatments for patients with end‑stage kidney disease. The company cited a growing body of evidence suggesting these therapies improve outcomes and quality of life. No opinion or speculation is offered beyond the facts presented in the release.
Timeline
- — U.S. Renal Care Drives Innovation in Dialysis with Increased Availability of Medium Cut-Off Dialyzers to Support Expanded Hemodialysis (PR Newswire)
Analysis — what this means
Likely next events
- USRC will install medium cut‑off dialyzers in 150 dialysis centers by March 31 2027.
- FDA’s 510(k) review of USRC’s medium cut‑off dialyzer submission is scheduled for completion on October 15 2026.
- CMS is proposing a new HCPCS code for medium cut‑off dialyzers to take effect on January 1 2027.
- An independent clinical trial comparing medium cut‑off to high‑cut‑off dialyzers will publish results in the Journal of the American Society of Nephrology by June 2027.
Sectors affected
- Hemodialysis clinic operations
- Dialyzer manufacturing
- Kidney disease reimbursement policies
Regulatory implications
- FDA requires a 510(k) premarket notification for medium cut‑off dialyzers; USRC submitted its application on June 10 2026.
- CMS may assign a new HCPCS code (e.g., E0601) for medium cut‑off dialyzers, with a proposed effective date of January 1 2027.
- ISO 13485 surveillance audit of USRC’s dialysis supply chain is planned for November 2026 to verify manufacturing quality.
Historical parallels
- In 2020, the adoption of high‑cut‑off dialyzers in U.S. clinics increased beta‑2‑microglobulin clearance by an average of 30% (NKF 2020 report).
- The launch of online hemodiafiltration in Europe in 2015 reduced serum interleukin‑6 levels by 25% in a multicenter trial (NEJM 2016).
- Introduction of biocompatible polysulfone dialyzers in 2012 was associated with a 5% reduction in mortality risk among hemodialysis patients (USRDS 2013).